These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27164964)

  • 1. Cannabis for Refractory Psoriasis-High Hopes for a Novel Treatment and a Literature Review.
    Derakhshan N; Kazemi M
    Curr Clin Pharmacol; 2016; 11(2):146-7. PubMed ID: 27164964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of psoriasis and their relevance.
    Nakajima K; Sano S
    J Dermatol; 2018 Mar; 45(3):252-263. PubMed ID: 29226571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
    J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New topical treatments for psoriasis.
    Chiricozzi A; Pitocco R; Saraceno R; Nistico SP; Giunta A; Chimenti S
    Expert Opin Pharmacother; 2014 Mar; 15(4):461-70. PubMed ID: 24392930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases.
    Milando R; Friedman A
    Am J Clin Dermatol; 2019 Apr; 20(2):167-180. PubMed ID: 30542832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Power of Combination Topical Therapy for Psoriasis.
    Kircik LH; Zografos P
    J Drugs Dermatol; 2015 Oct; 14(10):1113-6. PubMed ID: 26461822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instability of topical ciclosporin emulsion for nail psoriasis.
    Prins AM; Vos K; Franssen EJ
    Dermatology; 2007; 215(4):362-3. PubMed ID: 17911999
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsoriatic drug development: challenges and new emerging therapies.
    García-Pérez ME; Jean J; Pouliot R
    Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):3-21. PubMed ID: 22022925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
    Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis.
    Zampetti A; Mastrofrancesco A; Flori E; Maresca V; Picardo M; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):1067-75. PubMed ID: 20074471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of cannabinoids in dermatology.
    Sheriff T; Lin MJ; Dubin D; Khorasani H
    J Dermatolog Treat; 2020 Dec; 31(8):839-845. PubMed ID: 31599175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosin treatment for psoriasis reduces skin leukocyte infiltration and secretion of inflammatory chemokines and angiogenic factors.
    Capriotti L; Didona B; Madonna S; Scarponi C; Pilla MA; Facchiano F; Cordella M; Cavani A; Failla CM
    Eur J Dermatol; 2018 Aug; 28(4):457-466. PubMed ID: 30129532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of Paeonia lactiflora Pallas extract (PE) on poly (I:C)-induced immune response of epidermal keratinocytes.
    Choi MR; Choi DK; Sohn KC; Lim SK; Kim DI; Lee YH; Im M; Lee Y; Seo YJ; Kim CD; Lee JH
    Int J Clin Exp Pathol; 2015; 8(5):5236-41. PubMed ID: 26191223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risankizumab for the treatment of psoriasis.
    Gu C; Yang J
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):851-857. PubMed ID: 31460804
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of in vitro antipsoriatic activity of selected Indian medicinal plants.
    Singh SK; Chouhan HS; Sahu AN; Narayan G
    Pharm Biol; 2015; 53(9):1295-301. PubMed ID: 25856701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger?
    Benhadou F; Mintoff D; Del Marmol V
    Dermatology; 2019; 235(2):91-100. PubMed ID: 30566935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsoriatic potential of Annona squamosa seed oil: An in vitro and in vivo evaluation.
    Bhoir SS; Vishwapathi V; Singh KK
    Phytomedicine; 2019 Feb; 54():265-277. PubMed ID: 30668377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.